Company profile
Ticker
DYAX
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
PPD • IQVIA • PRA Health Sciences • Charles River Laboratories International • Icon • Syneos Health • Medpace • Incyte • Zymergen • OmniAb ...
SEC CIK
Corporate docs
IRS number
43053198
Latest filings (excl ownership)
EFFECT
Notice of effectiveness
10 Feb 16
CT ORDER
Confidential treatment order
5 Feb 16
15-12G
Securities registration termination
1 Feb 16
CT ORDER
Confidential treatment order
1 Feb 16
25-NSE
Exchange delisting
22 Jan 16
8-K
Shire Completes Acquisition of Dyax
22 Jan 16
POS AM
Prospectus update (post-effective amendment)
22 Jan 16
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jan 16
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jan 16
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Jan 16
Latest ownership filings
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|